middle.news
How OncoSil Medical’s Record Sales and European Expansion Are Reshaping Pancreatic Cancer Treatment
9:44am on Friday 30th of January, 2026 AEDT
•
Healthcare
Read Story
How OncoSil Medical’s Record Sales and European Expansion Are Reshaping Pancreatic Cancer Treatment
9:44am on Friday 30th of January, 2026 AEDT
Key Points
Record 60% increase in dose unit sales year-on-year
First commercial OncoSil treatments in Portugal, Germany, and the UK
Positive interim survival data from OSPREY clinical registry
Successful hot production test run at new Sydney manufacturing facility
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ONCOSIL MEDICAL (ASX:OSL)
OPEN ARTICLE